Demographic survey of 600 patients with gynecologic cancers in Mashhad, Iran in 1985-2012

Document Type : Original Article

Authors

1 Resident of Community Medicine, Department of Community Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

2 Assistant Professor, Department of Obstetrics and Gynecology, Ghaem Hospital, Women's Health Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

3 General Physician, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

4 General Physician, Students Research Committee, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

5 Assistant Professor, Department of Community Medicine, Cancer Research Center, Omid Hospital, Patient Safety Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract

Introduction: Lack of accurate, adequate and reliable information about malignancies of the female reproductive system in our country is sensible, this study was performed with aim to evaluate demographic characteristics of 600 patients with gynecologic cancers referred to Mashhad Oncology clinic in order to determine the relative frequency and mean age in different gynecologic cancers in Iran over the past three decades
Methods: This descriptive, analytic, and cross-sectional study was performed with aim to evaluate the patients with gynecologic cancers referred to Mashhad Oncology-Radiotherapy clinic. Epidemiologic data were obtained from records of the patients referred to private oncology center from 1985 to 2012 by using checklist. The study's time was divided into three intervals: 1985-1994, 1995-2004 and 2005-2012. Data analysis was conducted by the SPSS software (version 11.5), and Chi-square, Kolmogrov-Smirnov, Kruskal-Wallis, and ANOVA. PResults: A total of 579 cases were analyzed. Overall, the most frequent cancers was cervical cancer (43.5%), The relative frequency of gynecological cancers had significant differences among three intervals (P<0.001). Cervical cancer was the most frequent cancer in the first and second time periods, but uterine cancer had the highest relative frequency during the third interval. The mean age of patients at diagnosis was 48.63± 14.6 years that had significant differences among cancer types (P<0.001). The highest (56.1±10.7) and lowest (28.5±11.0) means of age were related to vagina cancer and trophoblastic cancer, respectively. Increased mean age at diagnosis for uterine cancer (P=0.026) and ovarian cancer (P=0.003) was statistically significant.
Conclusion: Cervical cancer was the most frequent cancer in our patients. The highest mean age was related to cervical cancer and lowest one was related to trophoblastic cancer. The mean age at diagnosis had ascending trend during three decades.

Keywords


  1. Hajian K, Firouzjahi AR, Kia MT. Pattern of age distribution of different cancers Babol, 2001. Res Med 2003; 27(3):239-45. (Persian).
  2. Azizi F, Hatami H, Janghorbani M. Epidemiology and control of prevalent diseases in Iran. 2th ed. Tehran: Khosravi Publication; 2004.
  3. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61(4):212-36.
  4. Yahyapour Y, Mahmoudi M. Prevalence of cancer in Mazandaran. Education and health researches office. Babol: Annual Activities Publisher; 2003. P. 6. (Persian).
  5. Amiri M, Kunst AE, Janssen F, Mackenback JP. Trends in stomach cancer mortality in relation to living conditions in childhood. A study among cohorts born between 1860 and 1939 in seven European countries. Eur J Cancer 2006; 42(18):3212-8.
  6. van Lier EA, van Kranen HJ, van Vliet JA, Rahmat-Langendoen JC. Estimated number of new cancer cases attributable to infection in the Netherlands in 2003. Cancer Lett 2008; 272(2):226-31.
  7. Iavari PM, Mousavi Zadeh M, Sadrolhefazi B, Khodabakhshi R, Mehrabi I. Survey of breast cancer risk factors in women attending in Shohadaie Tajrish hospital of Tehran in 2004. Pajoohande J 2006; 11(1):55-61. (Persian).
  8. Garcia M, Jemal AW, Ward EM, Center MM, Hao Y, Thun MJ, et al. Global cancer facts & figures 2007. Atlanta, GA: American Cancer Society; 2007.
  9. Mousavi SM. Comprehensive National Cancer Control Program in Iran. Tehran, Iran: Center for Disease Control and Prevention, Ministry of Health publication; 2007.
  10. Anderson KC, Alsina M, Bensinger W, Biermann JS, Chanan-Khan A, Cohen AD, et al. NCCN clinical practice guidelines in oncology: multiple myeloma. J Natl Comprehen Cancer Network 2009; 7(9):908.
  11. Esmail Nasab N, Moradi G, Zareie M, Ghaderi E, Gheytasi B. Survey of epidemiologic status and incidence rates of cancers in the patients above 15 years old in Kurdistan province. Sci J Kurdistan Univ Med Sci 2007; 11(4):18-25. (Persian).
  12. Zahedi MJ, Darvish Moghadam S, Haya Tbakhsh Abbasi M, Zeinalinejad H. The incidence rate of gastrointestinal tract cancers in Kerman province during 1996-2000. J Kerman Univ Med Sci; 12(3):153-8. (Persian).
  13. Davoodabadi A, Sharifi H, Erfan N, Dianati M, Abdolrahim Kashi E. An epidemiologic and clinical survey on gastric cancer patients referred to Shahid Beheshti hospital of Kashan during 1994-2001. Razi J Med Sci 2003; 10(34):211-20. (Persian).
  14. Mitchell RS, Padwal RS, Chuch AW, Klarenbach SW. Cancer screening among the overweight and obese in Canada. Am J Prev Med 2008; 35(2):127-32.
  15. Morris CR, Rodriguez AO, Epstein J, Cress RD. Declining trends of epithelial ovarian cancer in California. Gyneol Oncol 2008; 108(9):207-13.
  16. .Sasco AJ, Ah-Song R, Gendre I, Zlatoff P, Bobin JY, Hallonet P, et al. Bull Cancer 1997; 84(1):51-60.
  17. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58(2):71-96.
  18. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94(2):153-6.
  19. Arab M, Khayamzadeh M, Mohit M, Hosseini M, Anbiaee R, Tabatabaeefar M, et al. Survival of ovarian cancer in Iran: 2000-2004. Asian Pac J Cancer Prev 2009; 10(2):555-8.
  20. Hirabayashi Y, Marugame T. Comparison of time trends in ovary cancer mortality (1990-2006) in the world, from the WHO Mortality Database. Jpn J Clin Oncol 2007; 39(12):860-1.
  21. Berek JS, Adashi EY, Hillard PA, Novak ER. Novak’s Gynecology. 1st ed. Trans: Valdan M. Tehran: Naslehfarda Publishing; 2007. P. 1133-4. (Persian).
  22. Annual National Cancer Registration Report 2005–2006. Tehran, Iran: Iranian: Ministry of Health and Medical Education, Center for Disease Control and Prevention, Non-communicable Deputy Cancer Office; 2007. (Persian).
  23. Iranian Annual of National Cancer Registration Report. Tehran: Ministry of Health and Medical Education, Center for Disease Control & Prevention, Noncommunicable Deputy, Cancer Office; 2008.
  24. Thomas DB, Ray RM. Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Am J Epidemiol 1996; 144(3):281-9.
  25. Rodriguez T, Altieri A, Chatenoud L, Gallus S, Bosetti C, Negri E, et al. Risk factors for oral and pharyngeal cancer in young adults. Oral Oncol 2004; 40(2):207-13.
  26. Ramezani R, Nadali F, Modiran M, Arjmandpour M, Salavati F, Fazeli M, et al. National comprehensive cancer control program. Tehran: Department of Health Management of non-communicable diseases Cancer; 2012. (Persian).
  27. Nojomi M, Gilani M, Erfani A, Mozafari N, Mottaghi A. The study of frequency of risk factors of cervical cancer among women attending general hospitals in Tehran, 2005-2006. Razi J Med Sci 2007; 14(56):189-95. (Persian).
  28. Taheri N, Fazel A, Mahmoodzadeh H, Omranpour R, Roshandel G, Gharahjeh S, et al. Epidemiology of female reproductive cancers in Iran: results of the Gholestan Population-based Cancer Registry. Asian Pac J Cancer Prev 2014; 15(20):8779-82.
  29. Dolinsky C, Taylor J. Endometrial cancer: the basics. Pennsylvania: Abramson Cancer Center of the University of Pennsylvania; 2013.